New hemophilia drug aims for Long-Term bleeding control
NCT ID NCT03754790
Summary
This study is checking the long-term safety and effectiveness of a drug called fitusiran for people with severe hemophilia A or B. It involves about 281 male participants, aged 12 and older, who have already been in a previous fitusiran trial. The main goal is to see how well the drug controls bleeding episodes over many years and to monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Childhood Diseases Site Number : 8400007
Las Vegas, Nevada, 89135-3011, United States
-
Center for Inherited Blood Disorders (CIBD) Site Number : 8400016
Orange, California, 92868, United States
-
Children's Hospital Los Angeles Site Number : 8400019
Los Angeles, California, 90027, United States
-
Childrens Hospital Medical Center of Akron Site Number : 8400006
Akron, Ohio, 44308, United States
-
Investigational Site Number : 0360001
Camperdown, New South Wales, 2050, Australia
-
Investigational Site Number : 0360002
Murdoch, Western Australia, 6961, Australia
-
Investigational Site Number : 0360003
Prahran, Victoria, 3181, Australia
-
Investigational Site Number : 1240001
Montreal, Quebec, H1T 2M4, Canada
-
Investigational Site Number : 1560002
Guangzhou, 510515, China
-
Investigational Site Number : 1560003
Shanghai, 200025, China
-
Investigational Site Number : 1560004
Beijing, 100045, China
-
Investigational Site Number : 1560005
Hangzhou, 89147, China
-
Investigational Site Number : 1560006
Suzhou, 215006, China
-
Investigational Site Number : 1560007
Beijing, 100730, China
-
Investigational Site Number : 1560008
Jinan, 250013, China
-
Investigational Site Number : 1560009
Chengdu, 610091, China
-
Investigational Site Number : 1560010
Qingdao, 266555, China
-
Investigational Site Number : 1560011
Guiyang, 550004, China
-
Investigational Site Number : 1560012
Kunming, 650000, China
-
Investigational Site Number : 1560013
Lanzhou, 730000, China
-
Investigational Site Number : 1560014
Changsha, 410008, China
-
Investigational Site Number : 1580001
Taipei, 110, Taiwan
-
Investigational Site Number : 1580002
Changhua, 500, Taiwan
-
Investigational Site Number : 1580003
Taipei, 100, Taiwan
-
Investigational Site Number : 1580004
Taichung, 40705, Taiwan
-
Investigational Site Number : 1580005
Taipei, 112, Taiwan
-
Investigational Site Number : 1580007
Taoyuan, 33305, Taiwan
-
Investigational Site Number : 1580008
Taichung, 40201, Taiwan
-
Investigational Site Number : 2080001
Copenhagen, 2100, Denmark
-
Investigational Site Number : 2500002
Lyon, 69677, France
-
Investigational Site Number : 2500003
Paris, 75015, France
-
Investigational Site Number : 2760001
Berlin, 10249, Germany
-
Investigational Site Number : 2760003
Leipzig, 04103, Germany
-
Investigational Site Number : 3480002
Budapest, 1134, Hungary
-
Investigational Site Number : 3560001
Bangalore, 560034, India
-
Investigational Site Number : 3560002
Pune, 411001, India
-
Investigational Site Number : 3560004
Ranipet, 632517, India
-
Investigational Site Number : 3560005
Lucknow, 226003, India
-
Investigational Site Number : 3560007
Mumbai, 400 022, India
-
Investigational Site Number : 3560010
Pune, 411004, India
-
Investigational Site Number : 3720001
Crumlin, Dublin, 12, Ireland
-
Investigational Site Number : 3720002
Dublin, 8, Ireland
-
Investigational Site Number : 3760001
Ramat Gan, 5262100, Israel
-
Investigational Site Number : 3800002
Milan, Lombardy, 20122, Italy
-
Investigational Site Number : 3800004
Padua, Veneto, 35128, Italy
-
Investigational Site Number : 3920001
Nagoya, 4668560, Japan
-
Investigational Site Number : 3920002
Nishinomiya, Hyōgo, 663-8501, Japan
-
Investigational Site Number : 3920003
Kitakyushu, 8078555, Japan
-
Investigational Site Number : 3920004
Saitama, 330-8777, Japan
-
Investigational Site Number : 3920005
Isehara, Kanagawa, 2591193, Japan
-
Investigational Site Number : 3920008
Tokyo, 1600023, Japan
-
Investigational Site Number : 4100001
Busan, Busan, 602-739, South Korea
-
Investigational Site Number : 4100002
Daejeon, Daejeon, 35233, South Korea
-
Investigational Site Number : 4100003
Seoul, Seoul-teukbyeolsi, 03722, South Korea
-
Investigational Site Number : 4100004
Seoul, 3722, South Korea
-
Investigational Site Number : 4580001
Johor Bahru, 80100, Malaysia
-
Investigational Site Number : 4580002
Kota Kinabalu, 88586, Malaysia
-
Investigational Site Number : 4580003
Ampang, 68000, Malaysia
-
Investigational Site Number : 7100002
Port Elizabeth, 6001, South Africa
-
Investigational Site Number : 7920002
Adana, 01130, Turkey (Türkiye)
-
Investigational Site Number : 7920003
Izmir, TR-35100, Turkey (Türkiye)
-
Investigational Site Number : 7920004
Akdeniz, 07059, Turkey (Türkiye)
-
Investigational Site Number : 7920005
Istanbul, 34093, Turkey (Türkiye)
-
Investigational Site Number : 7920006
Gaziantep, 27100, Turkey (Türkiye)
-
Investigational Site Number : 7920007
Samsun, 55200, Turkey (Türkiye)
-
Investigational Site Number : 7920008
Kayseri, 38039, Turkey (Türkiye)
-
Investigational Site Number : 7920012
Bornova, 35100, Turkey (Türkiye)
-
Investigational Site Number : 8040001
Kyiv, 04060, Ukraine
-
Investigational Site Number : 8040002
Lviv, 79044, Ukraine
-
Investigational Site Number : 8040003
Kyiv, 1135, Ukraine
-
Investigational Site Number : 8040004
Mykolaiv, 54058, Ukraine
-
Investigational Site Number : 8260001
London, London, City of, SE1 9RT, United Kingdom
-
Investigational Site Number : 8260004
Glasgow, G4 0SF, United Kingdom
-
Nemours Children's Clinic Site Number : 8400008
Jacksonville, Florida, 32207, United States
-
Phoenix Childrens Hospital Site Number : 8400009
Phoenix, Arizona, 85016, United States
-
Rush University Medical Center -1725 W Harrison St Site Number : 8400001
Chicago, Illinois, 60612-3863, United States
-
St Joseph's Children's Hospital of Tampa Site Number : 8400002
Tampa, Florida, 33607, United States
-
University of Michigan Hospital - 1500 E Medical Center Dr Site Number : 8400012
Ann Arbor, Michigan, 48109-5000, United States
-
~Massachusetts General Hospital Site Number : 8400011
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.